Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$453M |
| 2 |
CELG
Celgene Corp
CELG
|
+$391M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$389M |
| 4 |
GE Aerospace
GE
|
+$378M |
| 5 |
Johnson & Johnson
JNJ
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$307M |
| 2 |
Costco
COST
|
+$279M |
| 3 |
Lowe's Companies
LOW
|
+$273M |
| 4 |
Microsoft
MSFT
|
+$230M |
| 5 |
Chevron
CVX
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Technology | 14.11% |
| 3 | Financials | 10.92% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Real Estate | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
Tootsie Roll Industries
TR
$3.06B
| $12.6M | 0.01% |
420,244
-16,726
| -4% | -$524K |
|
1252
ManpowerGroup
MAN
$2.66B
| $12.6M | 0.01% |
130,452
+87,400
| +203% | +$7.96M |
|
1253
Huron Consulting
HURN
$2.41B
| $12.6M | 0.01% |
249,358
+9,900
| +4% | +$484K |
|
1254
Park National Corp
PRK
$3.75B
| $12.6M | 0.01% |
126,405
+3,405
| +3% | +$330K |
|
1255
Helen of Troy
HELE
$704M
| $12.6M | 0.01% |
96,110
-26,600
| -22% | -$3.48M |
|
|
OMN
1256
DELISTED
OMNOVA Solutions Inc.
OMN
| $12.5M | 0.01% |
2,013,021
+37,600
| +2% | +$251K |
|
1257
Xerox
XRX
$414M
| $12.5M | 0.01% |
354,024
-490,325
| -58% | -$16.4M |
|
1258
National Presto Industries
NPK
$992M
| $12.5M | 0.01% |
133,600
-3,800
| -3% | -$387K |
|
1259
Regions Financial
RF
$27.1B
| $12.5M | 0.01% |
+833,721
| New | +$12.3M |
|
1260
Churchill Downs
CHDN
$6.17B
| $12.4M | 0.01% |
216,312
+167,564
| +344% | +$8.41M |
|
1261
Enerpac Tool Group
EPAC
$1.89B
| $12.4M | 0.01% |
501,300
+54,100
| +12% | +$1.33M |
|
1262
Amphastar Pharmaceuticals
AMPH
$852M
| $12.4M | 0.01% |
588,000
+146,400
| +33% | +$3.06M |
|
1263
Invesco Ultra Short Duration ETF
GSY
$3.88B
| $12.4M | 0.01% |
245,800
+29,600
| +14% | +$1.49M |
|
1264
OneMain Financial
OMF
$7.46B
| $12.3M | 0.01% |
365,100
+238,300
| +188% | +$7.78M |
|
1265
Oppenheimer Holdings
OPY
$1.23B
| $12.3M | 0.01% |
451,400
+24,300
| +6% | +$632K |
|
1266
Gibraltar Industries
ROCK
$1.47B
| $12.3M | 0.01% |
304,400
+90,347
| +42% | +$3.51M |
|
1267
eGain
EGAN
$200M
| $12.2M | 0.01% |
1,500,600
-147,800
| -9% | -$1.34M |
|
1268
Scorpio Tankers
STNG
$3.92B
| $12.2M | 0.01% |
413,320
+178,900
| +76% | +$4.53M |
|
1269
Gray Television
GTN
$518M
| $12.2M | 0.01% |
743,750
-460,300
| -38% | -$9.12M |
|
1270
World Kinect Corp
WKC
$1.91B
| $12.2M | 0.01% |
338,673
+327,600
| +2,959% | +$10.3M |
|
1271
Benchmark Electronics
BHE
$2.95B
| $12.2M | 0.01% |
484,650
+24,150
| +5% | +$621K |
|
1272
LXP Industrial Trust
LXP
$3.58B
| $12.2M | 0.01% |
258,556
-61,780
| -19% | -$2.85M |
|
|
BMCH
1273
DELISTED
BMC Stock Holdings, Inc
BMCH
| $12.2M | 0.01% |
573,700
+435,700
| +316% | +$9.05M |
|
|
HMSY
1274
DELISTED
HMS Holdings Corp.
HMSY
| $12.2M | 0.01% |
375,412
-516,100
| -58% | -$15.8M |
|
|
BSMX
1275
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
| $12.1M | 0.01% |
1,586,626
-528,806
| -25% | -$4.09M |
|
Similar funds
Jim Simons's Q2 2019 Portfolio in Review
As of Q2 2019, Jim Simons held 3,913 positions worth $114B, up 3.3% from $110B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Jim Simons's Q2 2019 filing shows 495 new, 1,847 increased, 1,145 reduced and 397 closed positions. Its largest new stake was Apple: 9,290,160 shares worth $460M. The largest sale was UnitedHealth, an estimated $307M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Jim Simons's largest Q2 2019 buy was Apple: 9,290,160 shares worth $460M.
- Jim Simons added most to Celgene Corp in Q2 2019, an estimated $391M increase.
- Jim Simons's biggest Q2 2019 reduction was Microsoft, cutting an estimated $230M.
- Jim Simons fully exited UnitedHealth in Q2 2019, selling an estimated $307M.
- Jim Simons's ten largest holdings make up 9.1% of its $114B portfolio in Q2 2019.
- Jim Simons opened 495 new positions and closed 397 in Q2 2019.
- Jim Simons's portfolio value rose 3.3% quarter-over-quarter to $114B.
Based on Renaissance Technologies's 13F filing for Q2 2019, filed 12 Aug 2019.